Sequana Medical NV received premarket approval from the U.S. FDA for its Alfapump system to treat recurrent or refractory ascites due to liver cirrhosis. Data from the Poseidon pivotal study showed ...
WHAT YOU CAN DO: Current Akero shareholders who have held Akero shares since on or before September 13, 2022, can seek corporate reforms, the return of funds spent defending litigation back to the ...
drake wife Roche reaches €260 million R&D collaboration to develop innovative treatments for immune diseases Cell Journal: New method for diagnosing liver cirrhosis using feces has an accuracy rate of ...
INR:1734. 100 free slots Yangtze River Pharmaceuticals is the first company to pass the review! Breaking the monopoly of Chinese biopharmaceuticals Aier Eye Hospit ...
INR:8767. bhoot wala jethalal Nature sub-journal: Relaxin gene therapy is expected to bring new hope to patients with cirrhosis "Medical Speed Reading S ...
INR:1805. satta galli First instance verdict: pharmacy chairman sentenced to 15 years in prison Zhengda Tianqing's Class 1 hepatitis B new drug approved for clinical ...
Relaxin gene therapy is expected to bring new hope to patients with cirrhosis A pharmaceutical company was warned for not complying with GMP during the inspection process The latest approval documents ...